Stevanato Group Inaugurates New Plant in Cisterna di Latina
Stevanato Group has recently launched its Cisterna di Latina plant.
Global Pharma | 31/05/2024 | By Aishwarya | 721
Sanofi Announces Complete Acquisition of Inhibrx
Sanofi has recently announced the complete acquisition of Inhibrx, Inc.
Global Pharma | 31/05/2024 | By Aishwarya | 249
Merck Signs MoU with KAIST to Boost Scientific Research
Merck has signed a non-binding Memorandum of Understanding (MoU) with the Korea Advanced Institute of Science and Technology (KAIST).
Global Pharma | 31/05/2024 | By Aishwarya | 354
PharmaLytica 2024 Commences Successfully in Hyderabad
Informa Markets India has announced the successful commencement of the 10th edition of PharmaLytica 2024 at HITEX, Hyderabad.
Global Pharma | 31/05/2024 | By Aishwarya | 984
Nxera Pharma to Receive USD 4.6 Million from Centessa
Nxera Pharma has been expecting to receive USD 4.6 million in milestone payments from Centessa Pharmaceuticals under a license agreement regarding Nxera technology used to help design Centessa’s novel orexin receptor 2 (OX2R) agonist, ORX750.
Global Pharma | 30/05/2024 | By Aishwarya | 523
H.E.L Group Expands its Sales Newtowk with Addition of Two Specialist Distributors
H.E.L Group (H.E.L) has expanded its global sales network with the appointment of two distributors: Paralab and ProAnalytics.
Global Pharma | 30/05/2024 | By Aishwarya | 703
Merck Announces Acquisition of EyeBio
Merck has signed a definitive agreement under which Merck, through a subsidiary, will acquire EyeBio.
Global Pharma | 30/05/2024 | By Aishwarya | 623
HanAll Biopharma and Turn Bio to Develop Novel Treatments for Eye and Ear Diseases
HanAll Biopharma Co., Ltd. has signed an exclusive licensing deal with Turn Biotechnologies, Inc., a pre-clinical stage biopharmaceutical company focused on cellular repair through epigenetic reprogramming.
Global Pharma | 29/05/2024 | By Aishwarya | 2558
Reddy Pharma Iberia and Theranica Launch Nerivio in Spain
Dr. Reddy's Laboratories Ltd. and its subsidiaries have introduced Nerivio in Spain through its step-down subsidiary, Reddy Pharma Iberia S.A.
Global Pharma | 29/05/2024 | By Aishwarya | 1093
Gerresheimer Expands Capacities for Medical Systems in USA
Gerresheimer is significantly expanding its production capacities for medical systems such as inhalers and autoinjectors in the United States.
Global Pharma | 28/05/2024 | By Manvi | 376
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy